Evidence map›Paper›PMID 38189661›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2024

Marital Status, Living Arrangement, and Survival among Individuals with Advanced Prostate Cancer in the International Registry for Men with Advanced Prostate Cancer.

Naiyu Chen, Colleen B McGrath, Caroline I Ericsson, Jane B Vaselkiv, Emily M Rencsok, Konrad H Stopsack, Hannah E Guard, Karen A Autio, Dana E Rathkopf, Deborah Enting and 27 more

Open access · greenAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors at 20 institutions in 16 countries.

Naiyu ChenDepartment of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.ORCID 0000-0003-3733-7654
Colleen B McGrathDepartment of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.ORCID 0000-0003-4542-2955
Caroline I EricssonDepartment of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.ORCID 0000-0001-6732-7006
Jane B VaselkivDepartment of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.ORCID 0000-0001-7702-9504
Emily M RencsokDepartment of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.ORCID 0000-0002-6935-1410
Konrad H StopsackDepartment of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.ORCID 0000-0002-0722-1311
Hannah E GuardDepartment of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.ORCID 0000-0001-6839-3793
Karen A AutioDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.ORCID 0000-0003-0720-0390
Dana E RathkopfDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.ORCID 0000-0002-4503-7582
Deborah EntingGuy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.ORCID 0000-0001-7508-7540
Rhonda L BittingDurham VA Health Care System, Durham, North Carolina.ORCID 0000-0002-5253-0551
Joaquin MateoVall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital Campus, Barcelona, Spain.ORCID 0000-0001-5336-2548
Charles W GithiakaDepartment of Surgery, University of Nairobi, Nairobi, Kenya.ORCID 0000-0003-1733-3832
Kim N ChiBC Cancer, Vancouver, British Columbia, Canada.ORCID 0000-0002-3782-7226
Heather H ChengUniversity of Washington and Fred Hutchinson Cancer Center, Seattle, Washington.ORCID 0000-0002-1365-0702
Ian D DavisMonash University Faculty of Medicine, Melbourne, Australia.ORCID 0000-0002-9066-8244
Simon G AndersonThe Glasgow-Caribbean Centre for Development Research and the Caribbean Institute of Health Research, The University of the West Indies, Bridgetown, Barbados.ORCID 0000-0002-8896-073X
Simone Ann Marie BadalAfrican-Caribbean Cancer Consortium, Philadelphia, Pennsylvania.ORCID 0000-0001-5214-3896
Anders BjartellDepartment of Urology, Skåne University Hospital, Malmö, Sweden.ORCID 0000-0002-5761-3786
Kjell M RussnesDepartment of Oncology, Oslo University Hospital, Oslo, Norway.ORCID 0009-0003-2402-8382
Elisabeth I HeathBarbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan.ORCID 0000-0003-1381-2713
Mark M PomerantzDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.ORCID 0000-0003-4914-1157
John C HeneganDepartment of Medicine, University of Mississippi Medical Center, Jackson, Mississippi.ORCID 0000-0002-2807-2060
Terry HyslopSidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.ORCID 0000-0002-3930-8876
Emilio EstebanDepartment of Medical Oncology, Hospital Universitario Central of Asturias, ISPA, Oviedo, Spain.ORCID 0000-0002-2980-5254
Aurelius OmlinOnkoZentrum, Zurich, Switzerland.ORCID 0000-0002-4783-4788
Ray McDermottSt Vincent's University Hospital and Cancer Trials Ireland, Dublin, Ireland.ORCID 0000-0002-8952-4315
Andre P FayPUCRS School of Medicine, Hospital Nora Teixeira, Porto Alegre, Brazil.ORCID 0000-0002-8588-7012
Ademola Alabi PopoolaUniversity of Ilorin, Ilorin, Nigeria.ORCID 0000-0002-1850-2223
Camille RaginAfrican-Caribbean Cancer Consortium, Philadelphia, Pennsylvania.ORCID 0000-0003-0816-4942
Joel NowakCancer ABCs, Brooklyn, New York.ORCID 0000-0003-2131-9478
Travis GerkeProstate Cancer Clinical Trials Consortium, New York, New York.ORCID 0000-0002-9500-8907
Philip W KantoffDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.ORCID 0000-0001-7275-0597
Daniel J GeorgeDurham VA Health Care System, Durham, North Carolina.ORCID 0000-0003-1499-7203
Kathryn L PenneyDepartment of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.ORCID 0000-0002-2815-3450
Lorelei A MucciDepartment of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.ORCID 0000-0002-2551-4927
IRONMAN Registry
Harvard University · USMemorial Sloan Kettering Cancer Center · USDurham VA Health Care System · USBC Cancer Agency · CABrigham and Women's Hospital · USCancer Trials Ireland · IECaribbean Disaster Emergency Management Agency · BBClinical Research Consortium · USDana-Farber Cancer Institute · USFox Chase Cancer Center · USFred Hutch Cancer Center · USGastroZentrum Hirslanden Zürich · CHGuy's and St Thomas' NHS Foundation Trust · GBHebron University · PSHospital de Clínicas de Porto Alegre · BRHospital Universitario Central de Asturias · ESOslo University Hospital · NOSchulman, Ronca & Bucuvalas · USSidney Kimmel Cancer Center · USSkåne University Hospital · SE

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Medical Scientist Training ProgramT32GM007753 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WALENSKY, LOREN DAVID · 1985 to 2021
$50.0M
Medical Scientist Training ProgramT32GM144273 · NIGMS · HARVARD MEDICAL SCHOOL · PI David Shumway Jones, Jacqueline A. Lees · 2022 to 2026
$14.7M
Racial disparities in advanced prostate cancer care: An analysis of treatment patterns and patient experienceF30CA264965 · NCI · HARVARD MEDICAL SCHOOL · PI RENCSOK, EMILY MAE · 2022 to 2025
$177k
NCI NIH HHS F30 CA264965NCI NIH HHS P30 CA008748NIGMS NIH HHS T32 GM007753NIGMS NIH HHS T32 GM144273
6 · The paper itself

Abstract

backgroundStudies have shown improved survival among individuals with cancer with higher levels of social support. Few studies have investigated social support and overall survival (OS) in individuals with advanced prostate cancer in an international cohort. We investigated the associations of marital status and living arrangements with OS among individuals with advanced prostate cancer in the International Registry for Men with Advanced Prostate Cancer (IRONMAN).

methodsIRONMAN is enrolling participants diagnosed with advanced prostate cancer (metastatic hormone-sensitive prostate cancer, mHSPC; castration-resistant prostate cancer, CRPC) from 16 countries. Participants in this analysis were recruited between July 2017 and January 2023. Adjusting for demographics and tumor characteristics, the associations were estimated using Cox regression and stratified by disease state (mHSPC, CRPC), age (<70, ≥70 years), and continent of enrollment (North America, Europe, Other).

resultsWe included 2,119 participants with advanced prostate cancer, of whom 427 died during up to 5 years of follow-up (median 6 months). Two-thirds had mHSPC. Most were married/in a civil partnership (79%) and 6% were widowed. Very few married participants were living alone (1%), while most unmarried participants were living alone (70%). Married participants had better OS than unmarried participants [adjusted HR: 1.44; 95% confidence interval (CI): 1.02-2.02]. Widowed participants had the worst survival compared with married individuals (adjusted HR: 1.89; 95% CI: 1.22-2.94).

conclusionsAmong those with advanced prostate cancer, unmarried and widowed participants had worse OS compared with married participants. IMPACT: This research highlighted the importance of social support in OS within this vulnerable population.

Indexed as

Prostatic Neoplasms, Castration-ResistantAgedEuropeHumansMaleMarital StatusRegistriesSocial Support

Identifiers

PMID38189661
PMCPMC10922505
OpenAlexW4390673425

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.